PDB Short entry for 1HK3 HEADER PLASMA PROTEIN 05-MAR-03 1HK3 TITLE HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (3,3',5,5'- TITLE 2 TETRAIODO-L-THYRONINE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS PLASMA PROTEIN, HORMONE-BINDING, LIPID-BINDING, THYROXINE, FAMILIAL KEYWDS 2 DYSALBUMINEMIC HYPERTHYROXINEMIA EXPDTA X-RAY DIFFRACTION AUTHOR I.PETITPAS,C.E.PETERSEN,C.E.HA,A.A.BHATTACHARYA,P.A.ZUNSZAIN, AUTHOR 2 J.GHUMAN,N.V.BHAGAVAN,S.CURRY REVDAT 5 13-DEC-23 1HK3 1 REMARK REVDAT 4 15-NOV-23 1HK3 1 ATOM REVDAT 3 24-JUL-19 1HK3 1 REMARK REVDAT 2 24-FEB-09 1HK3 1 VERSN REVDAT 1 16-MAY-03 1HK3 0 JRNL AUTH I.PETITPAS,C.E.PETERSEN,C.E.HA,A.A.BHATTACHARYA, JRNL AUTH 2 P.A.ZUNSZAIN,J.GHUMAN,N.V.BHAGAVAN,S.CURRY JRNL TITL STRUCTURAL BASIS OF ALBUMIN-THYROXINE INTERACTIONS AND JRNL TITL 2 FAMILIAL DYSALBUMINEMIC HYPERTHYROXINEMIA JRNL REF PROC.NATL.ACAD.SCI.USA V. 100 6440 2003 JRNL REFN ISSN 0027-8424 JRNL PMID 12743361 JRNL DOI 10.1073/PNAS.1137188100 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1111306.920 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 14599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 662 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2400 REMARK 3 BIN R VALUE (WORKING SET) : 0.3030 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 91 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4299 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 13 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.71000 REMARK 3 B22 (A**2) : -0.79000 REMARK 3 B33 (A**2) : 6.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 20.52000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.44 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.26 REMARK 3 BSOL : 43.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : T44.REVISED.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : T44.REVISED.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HK3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1290012299. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-02 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8019 REMARK 200 MONOCHROMATOR : SI CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14600 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 35.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1E7A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.64200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 SERUM ALBUMIN, REGULATES THE COLLOIDAL OSMOTIC PRESSURE OF REMARK 400 WATER, IT BINDS TO CA++, NA+, K+, FATTY ACIDS, HORMONES, REMARK 400 BILIRUBIN AND DRUGS REMARK 400 REMARK 400 ENGINEERED MUTATION: RESIDUE ARG (242) PRO REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 LYS A 4 REMARK 465 VAL A 77 REMARK 465 ALA A 78 REMARK 465 THR A 79 REMARK 465 LEU A 80 REMARK 465 ARG A 81 REMARK 465 GLU A 82 REMARK 465 THR A 83 REMARK 465 TYR A 84 REMARK 465 GLY A 85 REMARK 465 GLU A 86 REMARK 465 MET A 87 REMARK 465 ALA A 88 REMARK 465 VAL A 576 REMARK 465 ALA A 577 REMARK 465 ALA A 578 REMARK 465 SER A 579 REMARK 465 GLN A 580 REMARK 465 ALA A 581 REMARK 465 ALA A 582 REMARK 465 LEU A 583 REMARK 465 GLY A 584 REMARK 465 LEU A 585 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 25 CD1 REMARK 470 GLN A 33 CD OE1 NE2 REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 GLU A 57 CG CD OE1 OE2 REMARK 470 GLU A 60 CG CD OE1 OE2 REMARK 470 ASP A 63 CG OD1 OD2 REMARK 470 GLN A 104 CD OE1 NE2 REMARK 470 ASN A 111 CG OD1 ND2 REMARK 470 ARG A 114 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 117 CD NE CZ NH1 NH2 REMARK 470 ILE A 142 CD1 REMARK 470 GLU A 167 CG CD OE1 OE2 REMARK 470 ARG A 209 CD NE CZ NH1 NH2 REMARK 470 GLU A 227 CG CD OE1 OE2 REMARK 470 ILE A 264 CD1 REMARK 470 ILE A 271 CD1 REMARK 470 LYS A 276 CG CD CE NZ REMARK 470 GLU A 277 CG CD OE1 OE2 REMARK 470 GLU A 280 CG CD OE1 OE2 REMARK 470 ILE A 290 CD1 REMARK 470 GLU A 294 CG CD OE1 OE2 REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 LYS A 313 CG CD CE NZ REMARK 470 LYS A 359 CG CD CE NZ REMARK 470 LYS A 372 CD CE NZ REMARK 470 LYS A 378 CG CD CE NZ REMARK 470 ILE A 388 CD1 REMARK 470 LYS A 389 CD CE NZ REMARK 470 LYS A 402 CG CD CE NZ REMARK 470 LYS A 436 CD CE NZ REMARK 470 GLU A 442 CG CD OE1 OE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 GLU A 495 CG CD OE1 OE2 REMARK 470 ILE A 513 CD1 REMARK 470 LYS A 519 CG CD CE NZ REMARK 470 ILE A 523 CD1 REMARK 470 LYS A 536 CG CD CE NZ REMARK 470 LYS A 538 CG CD CE NZ REMARK 470 LYS A 545 CG CD CE NZ REMARK 470 ASP A 550 CG OD1 OD2 REMARK 470 GLU A 556 CG CD OE1 OE2 REMARK 470 LYS A 560 CG CD CE NZ REMARK 470 ASP A 562 CG OD1 OD2 REMARK 470 GLU A 570 CG CD OE1 OE2 REMARK 470 GLU A 571 CG CD OE1 OE2 REMARK 470 LYS A 573 CG CD CE NZ REMARK 470 LYS A 574 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 57 -0.18 -58.58 REMARK 500 ALA A 59 -178.56 -55.83 REMARK 500 LYS A 64 177.84 -52.04 REMARK 500 LEU A 69 -70.50 -60.19 REMARK 500 ALA A 92 27.67 -67.12 REMARK 500 GLU A 100 -9.97 -52.32 REMARK 500 ASN A 109 59.54 -155.41 REMARK 500 PRO A 147 8.33 -65.89 REMARK 500 TYR A 150 99.01 -56.75 REMARK 500 ALA A 175 -0.11 -59.52 REMARK 500 LEU A 178 -74.62 -68.01 REMARK 500 ILE A 271 -70.13 -127.16 REMARK 500 LYS A 276 -74.43 -57.81 REMARK 500 LEU A 283 -71.13 -30.36 REMARK 500 VAL A 293 152.24 -48.71 REMARK 500 ALA A 300 -106.16 -81.32 REMARK 500 ASP A 301 92.37 -55.36 REMARK 500 VAL A 310 -54.41 -138.58 REMARK 500 ALA A 322 62.46 -167.99 REMARK 500 ALA A 363 174.52 -52.59 REMARK 500 ALA A 364 -76.15 -56.45 REMARK 500 ALA A 449 -73.11 -67.88 REMARK 500 VAL A 469 10.63 -149.79 REMARK 500 SER A 480 125.44 -173.18 REMARK 500 PRO A 499 121.24 -34.73 REMARK 500 ALA A 504 -36.71 81.71 REMARK 500 ALA A 511 -57.75 -26.91 REMARK 500 ALA A 561 -148.40 65.72 REMARK 500 ASP A 562 -86.89 125.04 REMARK 500 LYS A 564 -69.64 -21.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T44 A3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T44 A3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T44 A3003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T44 A3004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AO6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1BJ5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1BKE RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- REMARK 900 IODOBENZOIC ACID REMARK 900 RELATED ID: 1BM0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E78 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E7A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL REMARK 900 ANESTHETIC PROPOFOL REMARK 900 RELATED ID: 1E7B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH HALOTHANE REMARK 900 RELATED ID: 1E7C RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL REMARK 900 ANESTHETIC HALOTHANE REMARK 900 RELATED ID: 1E7E RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID REMARK 900 RELATED ID: 1E7F RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID REMARK 900 RELATED ID: 1E7G RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1E7H RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID REMARK 900 RELATED ID: 1E7I RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID REMARK 900 RELATED ID: 1GNI RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9- OCTADECENOIC ACID (OLEIC REMARK 900 ACID) REMARK 900 RELATED ID: 1GNJ RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8 ,11,14-EICOSATETRAENOIC REMARK 900 ACID (ARACHIDONIC ACID) REMARK 900 RELATED ID: 1H9Z RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) REMARK 900 ENANTIOMER OF WARFARIN REMARK 900 RELATED ID: 1HA2 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) REMARK 900 ENANTIOMER OF WARFARIN REMARK 900 RELATED ID: 1HK1 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- REMARK 900 THYRONINE) REMARK 900 RELATED ID: 1O9X RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC REMARK 900 ACID) AND HEMIN REMARK 900 RELATED ID: 1UOR RELATED DB: PDB REMARK 900 X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED REMARK 900 BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE REMARK 900 MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1HK2 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE REMARK 900 RELATED ID: 1HK4 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE AND MYRISTIC ACID REMARK 900 RELATED ID: 1HK5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE AND REMARK 900 MYRISTIC ACID DBREF 1HK3 A 1 585 UNP P02768 ALBU_HUMAN 25 609 SEQADV 1HK3 PRO A 218 UNP P02768 ARG 242 ENGINEERED MUTATION SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA PRO LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU HET T44 A3001 24 HET T44 A3002 24 HET T44 A3003 24 HET T44 A3004 24 HETNAM T44 3,5,3',5'-TETRAIODO-L-THYRONINE FORMUL 2 T44 4(C15 H11 I4 N O4) FORMUL 6 HOH *13(H2 O) HELIX 1 1 SER A 5 GLY A 15 1 11 HELIX 2 2 GLY A 15 LEU A 31 1 17 HELIX 3 3 PRO A 35 ASP A 56 1 22 HELIX 4 4 SER A 65 THR A 76 1 12 HELIX 5 5 ARG A 98 LYS A 106 1 9 HELIX 6 6 GLU A 119 ASN A 130 1 12 HELIX 7 7 GLU A 131 HIS A 146 1 16 HELIX 8 8 TYR A 150 CYS A 169 1 20 HELIX 9 9 CYS A 177 PHE A 223 1 47 HELIX 10 10 GLU A 227 GLY A 248 1 22 HELIX 11 11 ASP A 249 ASN A 267 1 19 HELIX 12 12 GLN A 268 ILE A 271 5 4 HELIX 13 13 LYS A 274 GLU A 280 1 7 HELIX 14 14 PRO A 282 VAL A 293 1 12 HELIX 15 15 SER A 304 VAL A 310 1 7 HELIX 16 16 ASP A 314 ARG A 336 1 23 HELIX 17 17 SER A 342 CYS A 361 1 20 HELIX 18 18 ASP A 365 TYR A 370 1 6 HELIX 19 19 GLU A 376 VAL A 415 1 40 HELIX 20 20 SER A 419 LYS A 432 1 14 HELIX 21 21 LYS A 432 CYS A 438 1 7 HELIX 22 22 PRO A 441 THR A 467 1 27 HELIX 23 23 SER A 470 GLU A 479 1 10 HELIX 24 24 ASN A 483 LEU A 491 1 9 HELIX 25 25 ALA A 504 THR A 508 5 5 HELIX 26 26 HIS A 510 THR A 515 5 6 HELIX 27 27 SER A 517 LYS A 536 1 20 HELIX 28 28 THR A 540 LYS A 560 1 21 HELIX 29 29 ASP A 563 LEU A 575 1 13 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.04 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.04 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.03 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.02 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.03 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.03 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.03 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.02 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.03 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.05 CISPEP 1 GLU A 95 PRO A 96 0 0.00 SITE 1 AC1 10 TYR A 150 LYS A 195 LYS A 199 TRP A 214 SITE 2 AC1 10 PRO A 218 LEU A 219 ARG A 222 LEU A 238 SITE 3 AC1 10 ARG A 257 ILE A 290 SITE 1 AC2 8 LEU A 387 GLN A 390 ASN A 391 ALA A 406 SITE 2 AC2 8 LEU A 407 ARG A 410 TYR A 411 SER A 489 SITE 1 AC3 6 ALA A 300 THR A 506 PHE A 507 THR A 508 SITE 2 AC3 6 LYS A 524 PHE A 551 SITE 1 AC4 5 PHE A 507 ALA A 528 LEU A 532 VAL A 547 SITE 2 AC4 5 LEU A 575 CRYST1 59.328 89.284 60.526 90.00 100.80 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016855 0.000000 0.003214 0.00000 SCALE2 0.000000 0.011200 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016820 0.00000